Intercept Pharmaceuticals, Inc.
ICPTDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001270073
Intercept Pharmaceuticals, Inc. was delisted in 2023; its insiders filed their last Form 4 on Nov 13, 2023; 146 institutions reported holding it in 13F filings for Q3 2023, worth $724.6M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Intercept Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Intercept Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Bradbury Daniel | Director | 0 | Nov 13, 2023 | 0 |
| Akkaraju Srinivas | Director | 0 | Nov 13, 2023 | 0 |
| Santini Gino | Director | 0 | Nov 13, 2023 | 0 |
| Sblendorio Glenn | Director | 0 | Nov 13, 2023 | 0 |
| Berrey M Michelle | President, R&D and CMO | 0 | Nov 13, 2023 | 0 |
| Fundaro Paolo | Director | 0 | Nov 13, 2023 | 0 |
| Pruzanski Mark | Director | 0 | Nov 13, 2023 | 0 |
| Richardson Linda M | EVP & Chief Commercial Officer | 0 | Nov 13, 2023 | 0 |
| Benatti Luca | Director | 0 | Nov 13, 2023 | 0 |
| Gottesdiener Keith Michael | Director | 0 | Nov 13, 2023 | 0 |
| Saik Andrew | EVP & Chief Financial Officer | 0 | Nov 13, 2023 | 0 |
| Rosa-Bjorkeson Dagmar | Director | 0 | Nov 13, 2023 | 0 |
| Durso Jerome Benedict | CEO | 0 | Nov 13, 2023 | 0 |
| Ford David A | Chief Human Resources Officer | 0 | Nov 13, 2023 | 0 |
| Miller-Rich Nancy | Director | 0 | Nov 13, 2023 | 0 |
| Freedberg Jared | General Counsel | 0 | Nov 13, 2023 | 0 |
| Venezia Rocco | Chief Accounting Officer | 0 | Nov 13, 2023 | 0 |
| Ball Bryan | Chief Qual. Officer & SVP Ops. | 25,178 | Jul 13, 2022 | 0 |
| Cawkwell Gail | SVP, Med Affairs, Safety & PV | 35,740 | Feb 15, 2022 | 0 |
| DeFrancesco Lisa | SVP, IR & Corp. Affairs | 10,308 | Jan 4, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.